U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263204) titled 'AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy' on Nov. 17.
Brief Summary: By harnessing artificial intelligence to decode the 12-lead electrocardiogram, the project will enable precise ECG-based phenotyping of hypertrophic cardiomyopathy-accurately classifying septal, apical, and other morphologic subtypes-while simultaneously differentiating HCM from hypertensive heart disease, aortic stenosis, and other phenocopy disorders.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Hypertrophic Cardiomyopathy (HCM)
Left Ventricular Hypertrophy
Recruitment Status: RECRUITING
Sponsor: Second Affiliated H...